These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32618442)

  • 21. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
    Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
    Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Blau syndrome:First molecularly confirmed report from India.
    Janarthanan M; Poddar C; Sudharshan S; Seabra L; Crow YJ
    Indian J Ophthalmol; 2019 Jan; 67(1):165-167. PubMed ID: 30574935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early-onset sarcoidosis/Blau syndrome].
    Kambe N; Satoh T; Nakano M; Nakamura Y; Matsue H
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):378-81. PubMed ID: 22041425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel NOD2-associated Mutation and Variant Blau Syndrome: Phenotype and Molecular Analysis.
    Ebrahimiadib N; Samra KA; Domina AM; Stiles ER; Ewer R; Bocian CP; Foster CS
    Ocul Immunol Inflamm; 2018; 26(1):57-64. PubMed ID: 27419275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency.
    Parackova Z; Bloomfield M; Vrabcova P; Zentsova I; Klocperk A; Milota T; Svaton M; Casanova JL; Bustamante J; Fronkova E; Sediva A
    J Clin Immunol; 2020 Jan; 40(1):165-178. PubMed ID: 31760574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features of Blau syndrome and early-onset sarcoidosis and associating CARD15/NOD2 gene mutations].
    Kanazawa N
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):123-32. PubMed ID: 17473515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.
    Mensa-Vilaro A; Cham WT; Tang SP; Lim SC; González-Roca E; Ruiz-Ortiz E; Ariffin R; Yagüe J; Aróstegui JI
    Arthritis Rheumatol; 2016 Apr; 68(4):1039-44. PubMed ID: 26606664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report.
    Dziedzic M; Marjańska A; Bąbol-Pokora K; Urbańczyk A; Grześk E; Młynarski W; Kołtan S
    Pediatr Rheumatol Online J; 2017 Jul; 15(1):57. PubMed ID: 28750667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Features in Chinese Patients with Blau Syndrome.
    Wu S; Zhong L; Sun Z; Zhu T; Song H; Sui R
    Ocul Immunol Inflamm; 2020; 28(1):79-85. PubMed ID: 30806112
    [No Abstract]   [Full Text] [Related]  

  • 30. Blau syndrome, the prototypic auto-inflammatory granulomatous disease.
    Wouters CH; Maes A; Foley KP; Bertin J; Rose CD
    Pediatr Rheumatol Online J; 2014; 12():33. PubMed ID: 25136265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of NOD2 Pathway Genes in Sarcoidosis Cases with Clinical Characteristics of Blau Syndrome.
    Bello GA; Adrianto I; Dumancas GG; Levin AM; Iannuzzi MC; Rybicki BA; Montgomery C
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1133-5. PubMed ID: 26517420
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of a novel missense mutation in the NOD2 gene in a Chinese child with early-onset sarcoidosis.
    Wang X; Zhang X; Zhang W; Sun J
    Indian J Dermatol Venereol Leprol; 2018; 84(5):645. PubMed ID: 29067935
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Profile in Genetically Proven Blau Syndrome: A Case Series from South India.
    Babu K; Rao AP
    Ocul Immunol Inflamm; 2021 Feb; 29(2):250-256. PubMed ID: 32293936
    [No Abstract]   [Full Text] [Related]  

  • 34. Blau Syndrome: A Systemic Granulomatous Disease of Cutaneous Onset and Phenotypic Complexity.
    Rose CD
    Pediatr Dermatol; 2017 Mar; 34(2):216-218. PubMed ID: 27874205
    [No Abstract]   [Full Text] [Related]  

  • 35. Lipogranulomatous subconjunctival nodules: a novel presentation in Blau syndrome.
    Ahmad M; Hermanson ME; Enzenauer R; Palestine A; Lin C; Meeks N; McCourt E
    J AAPOS; 2017 Jun; 21(3):249-251. PubMed ID: 28532706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational model to analyze and characterize the functional mutations of NOD2 protein causing inflammatory disorder - Blau syndrome.
    Thirumal Kumar D; Udhaya Kumar S; Nishaat Laeeque AS; Apurva Abhay S; Bithia R; Magesh R; Kumar M; Zayed H; George Priya Doss C
    Adv Protein Chem Struct Biol; 2020; 120():379-408. PubMed ID: 32085886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing Blau Syndrome from Systemic Sarcoidosis.
    Kaufman KP; Becker ML
    Curr Allergy Asthma Rep; 2021 Feb; 21(2):10. PubMed ID: 33560445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
    Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
    Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome.
    Ueki Y; Takimoto-Ito R; Saito MK; Tanizaki H; Kambe N
    Front Immunol; 2023; 14():1211240. PubMed ID: 37415984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing in three children with sporadic Blau syndrome, one of them co-presenting with recurrent polyserositis.
    Córdova-Fletes C; Rangel-Sosa MM; Martínez-Jacobo LA; Becerra-Solano LE; Arellano-Valdés CA; Tlacuilo-Parra JA; Galán-Huerta KA; Rivas-Estilla AM; Hernandez-Orozco AA; García-Ortiz JE
    Autoimmunity; 2020 Sep; 53(6):344-352. PubMed ID: 32597225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.